Preparation, characterization and enzyme inhibition of methylmethacrylate copolymer nanoparticles with different hydrophilic polymeric chains

被引:10
作者
Qian, Feng
Cui, Fuying
Yin, Chunhua [1 ]
机构
[1] Fudan Univ, Sch Life Sci, Dept Pharmaceut Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China
[2] Fudan Univ, Sch Life Sci, Dept Biochem, Shanghai 200433, Peoples R China
关键词
methylmethacrylate copolymer; nanoparticles; enzyme inhibition;
D O I
10.1016/j.eurpolymj.2006.01.016
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Methylmethacrylate copolymer nanoparticles with different hydrophilic chains were prepared by the free radical polymerization of methylmethacrylate with N-isopropylacrylamide (NIPAAm), N-methacrylic acid (MAA), N-trimethylaminoethylmethacrylate chloride (TMAEMC) or N-dimethylaminoethylmethacrylate hydrochloride (DMAEMC). These particles were characterized by particle size and zeta potential. The polymerization conditions were shown to influence the particle size and surface charge. Particle sizes of MMA-NIPAAm nanoparticles after 3 h of reaction reached constant level at 180 nm. An increasing amount of total monomer (0.5-5%) would result in the nanoparticles of particle size of 115-204 urn for 30% NIPAAm of the total monomer. In the same range of 5-40% NIPAAm of the total monomer, the particle size decreased from 280 to 170nm. The concentration of the initiator APS up to a concentration of 0.2% for MMA-TMAEMC and 0.1% for MMA-NIPAAm showed no effect on the particle size of the final nanoparticle suspensions, while higher concentration would lead to aggregation in the polymerization process. MMA-NIPAAm nanoparticles were pH-dependent in zeta potential at pH 1-12 values reducing from 12.2 mV to - 16.8 mV, respectively. Nanoparticles were incubated with pepsin and trypsin at 37 C for 20 min and their enzyme inhibition was determined. The activity of pepsin decreased to 27% in the presence of MMA-NIPAAm nanoparticles, and MMA-MAA nanoparticles reduced the activity of trypsin to 39%, respectively. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1653 / 1661
页数:9
相关论文
共 23 条
[1]   SYNTHESIS AND POLYMERIZATION OF A STYRYL TERMINATED OLIGOVINYLPYRROLIDONE MACROMONOMER [J].
AKASHI, M ;
KIRIKIHIRA, I ;
MIYAUCHI, N .
ANGEWANDTE MAKROMOLEKULARE CHEMIE, 1985, 132 (JUN) :81-89
[2]  
COUVREUR P, 1982, Patent No. 432932
[3]  
Fitch R. M., 1969, J POLYM SCI C, V27, P95
[4]  
FIX J A, 1987, Journal of Controlled Release, V6, P151, DOI 10.1016/0168-3659(87)90072-1
[5]   NANOPARTICLES AS CARRIERS FOR ORAL PEPTIDE ABSORPTION - STUDIES ON PARTICLE UPTAKE AND FATE [J].
FLORENCE, AT ;
HILLERY, AM ;
HUSSAIN, N ;
JANI, PU .
JOURNAL OF CONTROLLED RELEASE, 1995, 36 (1-2) :39-46
[6]   Improvement of intestinal absorption of human calcitonin by chemical modification with fatty acids: Synergistic effects of acylation and absorption enhancers [J].
Fujita, T ;
Fujita, T ;
Morikawa, K ;
Tanaka, H ;
Iemura, O ;
Yamamoto, A ;
Muranishi, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 134 (1-2) :47-57
[7]   Cyclodextrins - Useful excipients for oral peptide administration? [J].
Haeberlin, B ;
Gengenbacher, T ;
Meinzer, A ;
Fricker, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 137 (01) :103-110
[8]   OPTIMIZATION OF PILOCARPINE LOADING ONTO NANOPARTICLES BY SORPTION PROCEDURES [J].
HARMIA, T ;
SPEISER, P ;
KREUTER, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 33 (1-3) :45-54
[9]  
HE J, 1994, CH J BIOCH PHARM, V15, P54